Screener
Paysign PAYS Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other Revenue | $562.4K-3.1% | $610.36K+7.2% | $558.37K+13.1% | $815.4K+50.4% | $580.52K+51.4% | |
| Pharma Industry | $14.65M+88.9% | $15.68M+81.9% | $9.6M+122% | $7.92M+142% | $7.75M+190% | |
| Plasma Industry | $13.04M+21.4% | $11.75M+24.9% | $12.6M+16.7% | $12.86M+12.4% | $10.74M-4.7% |
FAQ
- How does Paysign break its business down?
- Paysign (PAYS) reports revenue by product across 3 parts — Other Revenue, Pharma Industry and Plasma Industry. Each is extracted from the segment footnotes and tracked over time.
- Where does Paysign's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Paysign's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
